Synergy of Taxol and rhein lysinate associated with the downregulation of ERK activation in lung carcinoma cells

Effects of Monoclonal Antibodies against Human Stathmin Combined with Paclitaxel on Proliferation of the QG-56 Human Lung Carcinoma Cell Line

(2012) Shao-Fei Yuan et al.   Asian Pacific Journal of Cancer Prevention

Rhein lysinate inhibits cell growth by modulating various mitogen-activated protein kinases in cervical cancer cells

(2010) YONG-ZHAN ZHEN et al.   Oncology Letters

Rhein Lysinate Suppresses the Growth of Tumor Cells and Increases the Anti-Tumor Activity of Taxol in Mice

(2009) Ya-Jun Lin et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Blockade of the ERK or PI3K–Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib

(2009) Kei-ichi Ozaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice

(2008) Ya-Jun Lin et al.   ANTI-CANCER DRUGS

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways

(2008) P. Lunghi et al.   BLOOD

Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin

(2008) Myoung Woo Lee et al.   INTERNATIONAL JOURNAL OF CANCER

The Role of PPAR in the Cyclooxygenase Pathway in Lung Cancer

(2008) Saswati Hazra et al.   PPAR Research